17% of doctors say they will take a COVID-19 antibody in the event that it is approved before all clinical tests have been finished, as indicated by consequences of a Medscape survey.
17% of doctors said they would request or utilize the antibody; 63% said no; and 20% said they were uncertain. More youthful specialists were more probable to say they would not get an antibody under such conditions (68% of those more youthful than 55 years said no, versus 61% of those ages 55 years and elder.)
